Why Albumin is Important in Nutrition Assessment
Albumin is historically used in nutrition assessment because it strongly predicts mortality and morbidity, but it should never be interpreted in isolation as a nutritional marker because it is heavily influenced by inflammation, illness, liver disease, volume status, and protein losses—making it more accurately a marker of disease severity rather than nutritional status alone. 1
The Dual Nature of Albumin: Prognostic Power vs. Nutritional Specificity
Strong Prognostic Value
- Serum albumin is one of the best predictors of illness or death in patients with end-stage kidney disease (ESKD), with each 0.1 g/dL decrease associated with a 6% increase in death risk and 5% increase in days hospitalized. 1
- Lower albumin concentrations (<3.5 g/dL) are associated with higher odds of mortality over 10 years (OR 2.34,95% CI 1.33-4.10). 1
- Albumin concentrations <35 g/L are associated with decreased survival in hospitalized patients. 2
- A meta-analysis found that a 1.0 g/dL decrease in serum albumin increased odds of morbidity by 89% and mortality by 137%. 3
Critical Limitations as a Nutritional Marker
- Inflammatory cytokines directly downregulate albumin synthesis in the liver, causing hypoalbuminemia even when protein and caloric intake are adequate. 1, 2
- Albumin is a negative acute-phase reactant—serum levels decline during inflammation or infection regardless of nutritional status. 1, 2
- Patients with analbuminemia are not malnourished, and individuals with simple malnutrition are rarely hypoalbuminemic. 4
- A calorie- and protein-deficient diet does not reduce albumin synthesis and is not associated with hypoalbuminemia. 5
Multiple Non-Nutritional Factors Affecting Albumin Levels
Primary Confounding Factors
- Inflammation and acute illness: C-reactive protein and other positive acute-phase proteins are inversely correlated with serum albumin levels. 2
- Liver disease: Cirrhosis and chronic liver disease impair albumin production. 1, 2
- Volume expansion: Hemodilution from excess fluid decreases serum albumin concentration, particularly common in dialysis patients. 1, 2
- Protein losses: Urinary losses (nephrotic syndrome), dialysate losses (peritoneal dialysis), or gastrointestinal losses all contribute to hypoalbuminemia. 1, 2
- Age and comorbidities: Older patients tend to have lower albumin levels; cardiovascular disease and diabetes mellitus contribute to hypoalbuminemia. 1
- Metabolic acidosis: Can contribute to hypoalbuminemia in kidney disease. 1
The KDOQI 2020 Guideline Framework: How to Use Albumin Properly
Recommended Approach
- Biomarkers such as serum albumin should be considered complementary tools to assess nutritional status but should not be interpreted in isolation. 1
- In adults with CKD 5D on maintenance hemodialysis, serum albumin may be used as a predictor of hospitalization and mortality (Grade 1A evidence). 1
- Albumin should be used as part of a comprehensive evaluation that includes other nutritional assessment methods. 1
Specific Clinical Thresholds
- An individual with predialysis or stabilized serum albumin <30 mg/dL (for prealbumin) should be evaluated for protein-energy malnutrition. 1
- Albumin <3.5 g/dL warrants evaluation for both malnutrition and inflammatory processes. 1
- Albumin <38 g/L is significantly associated with higher mortality and morbidity. 1
Algorithmic Approach to Interpreting Low Albumin
Step 1: Measure Inflammatory Markers
- Check C-reactive protein (CRP) or high-sensitivity CRP to identify inflammation as the primary driver. 2, 3
- If CRP is elevated, hypoalbuminemia likely reflects inflammation rather than malnutrition. 1, 2
Step 2: Assess for External Protein Losses
- Measure urine albumin-to-creatinine ratio (uACR) to detect albuminuria. 2
- Severely increased albuminuria (≥300 mg/g) with hypoalbuminemia and edema suggests nephrotic syndrome. 2
- Consider stool studies if gastrointestinal protein loss is suspected. 2, 3
Step 3: Evaluate Hydration Status
- Assess for volume overload, as overhydration dilutes serum albumin concentration. 1, 2, 3
- This is particularly important in dialysis patients. 1
Step 4: Assess Liver Function
- Evaluate for liver disease or cirrhosis, which impairs albumin synthesis. 1, 2
- Check liver function tests and consider liver congestion from heart failure. 2
Step 5: Comprehensive Nutritional Assessment
- Use validated nutritional screening tools (Subjective Global Assessment, Mini Nutritional Assessment) rather than relying solely on albumin. 2
- Evaluate dietary protein and energy intake. 1, 3
- Consider body composition assessment when available. 2
- Measure other nutritional markers like prealbumin (shorter half-life, more sensitive to rapid changes). 1
Common Pitfalls to Avoid
Critical Errors in Interpretation
- Assuming hypoalbuminemia is solely due to malnutrition when inflammation may be the primary driver. 1, 2, 3
- Failing to recognize that albumin is a negative acute-phase reactant that decreases during inflammation. 2, 3
- Not considering the multiple non-nutritional factors that affect serum albumin levels. 2, 3
- Relying solely on albumin infusion to correct the underlying problem rather than addressing the cause. 3
- Using albumin as a quality care index, which encourages reflexive reliance on expensive and unproven interventions like dietary supplements. 4
What Albumin Actually Represents
- Albumin should be viewed as a marker of illness severity rather than nutrition alone. 4
- Hypoalbuminemia is a result rather than a cause of ill-health. 5
- Nutritional supplementation has not been clearly shown to raise levels of serum albumin. 4
- Therapy designed to increase albumin has limited benefit unless the underlying cause is addressed. 5
Monitoring Frequency in Specific Populations
Dialysis Patients
- Monitor serum albumin at least every 4 months in dialysis patients. 2
- More frequent monitoring is recommended during acute illness or when albumin is declining. 2
- Evaluate albumin in context of peritoneal transport type and delivered dialysis dose. 2
- Target ≥0.9 g/kg/day of normalized protein nitrogen appearance (nPNA) in dialysis patients. 2